JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB270785

Caspase 3/7 Staining Kit (Far Red)

Be the first to review this product! Submit a review

|

(2 Publications)

Caspases play important roles in apoptosis and inflammation.

Key facts

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Flow Cyt": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Fluorescence Microscopy": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Caspases play important roles in apoptosis and inflammation. Caspase 3/7 Staining Kit (Far Red) are used by researchers seeking to quantitate apoptosis via caspase activity in cultured cells. The fluorescent 660-DEVD-FMK caspase-3/7 inhibitor reagent allows researchers to assess caspase activation.

The fluorescent reagent 660-DEVD-FMK enters each cell and irreversibly binds to activated Caspase 3/7. Because the 660-DEVD-FMK reagent becomes covalently coupled to the active enzymes, it is retained within the cell, while any unbound 660-DEVD-FMK reagent diffuses out of the cell and is washed away. The remaining far red fluorescent signal is a direct measure of the active caspase enzyme activity present in the cell at the time the reagent was added. Cells that contain the bound 660-DEVD-FMK can be analyzed by fluorescence microscopy or flow cytometry. Cells labeled with the 660-DEVD-FMK reagent may be read immediately or preserved for 16 hours using the fixative. Unfixed samples may also be analyzed with Hoechst stain to detect changes in nuclear morphology.

Produced using a non-baculovirus expression system.

The target for this kit is Caspase 3/7.

NOTE: The number of tests per kit depends on the application being tested. This kit provides 50 tests for flow and 25 for imaging.

FLICA 660-DEVD-FMK caspase-3/7 inhibitor reagent contains the preferred binding sequence, Asp-Glu-Val-Asp (DEVD) for executioner caspases -3 and -7. This preferred caspase-3 and -7 binding sequence, DEVD, is labeled at the amino terminus end with a far-red fluorescent 660 dye and linked at the carboxyl end to a fluoromethyl ketone (FMK) reactive entity. The resulting cell permeant, fluorescent molecule, 660-DEVD-FMK, optimally excites at 660 nm and emits between 685-690 nm. A conventional red HeNe laser with a 633 nm excitation provides excellent excitation efficiency, enabling cells labeled with 660-DEVD-FMK to be analyzed with most flow cytometers, as well as fluorescence microscopes equipped with electronic grey scale image capabilities.

Kits are available for other caspases:

Poly Caspase Staining Kit (Far Red) (ab270783)

Caspase 1 Staining Kit (Far Red) (ab27084)

What's included?

{ "values": { "50Test": { "sellingSize": "50 Test", "publicAssetCode":"ab270785-50Test", "assetComponentDetails": [ { "size":"1 x 1 Vial", "name":"660-DEVD-FMK caspase-3/7 inhibitor reagent", "number":"AB270785-CMP03", "productcode":"" }, { "size":"1 x 6 mL", "name":"Fixative", "number":"AB270785-CMP02", "productcode":"" }, { "size":"1 x 15 mL", "name":"10X Apoptosis Wash Buffer", "number":"AB270785-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
+4°C

Product protocols

Target data

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 13:6797 PubMed36357392

2022

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Krach,Judith Stemick,Tom Boerstler,Alexander Weiss,Ioannis Lingos,Stephanie Reischl,Holger Meixner,Sonja Ploetz,Michaela Farrell,Ute Hehr,Zacharias Kohl,Beate Winner,Juergen Winkler

Acta neuropathologica 144:413-435 PubMed35778567

2022

Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Florian Krach,Emily C Wheeler,Martin Regensburger,Tom Boerstler,Holger Wend,Anthony Q Vu,Ruth Wang,Stephanie Reischl,Karsten Boldt,Ranjan Batra,Stefan Aigner,John Ravits,Juergen Winkler,Gene W Yeo,Beate Winner
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com